What is MedWellAI Inc.'s earnings per share (EPS)?

MedWellAI Inc. (MWAI) reported diluted earnings per share of $-0.49 for fiscal year 2025. This represents a 82.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

MedWellAI Inc. Financials

MWAI

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE June

This page shows MedWellAI Inc. (MWAI) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI MWAI FY2025 2026-04-22

Loss reduction came mainly from a cost reset, while tiny revenue and a liability-heavy balance sheet still dictate how MWAI operates.

From FY2023 to FY2025, net loss contracted from $25.5M to $3.6M. With SG&A down to $2.6M while revenue was only $595K, the improvement looks like a cost reset rather than a rebuilt sales engine.

The current position is liquidity-tight: cash was $401K against current liabilities of $3.1M, so even ordinary payables and accruals likely dominate day-to-day cash decisions. A 0.1x current ratio and negative equity mean the business is relying more on obligations staying in place than on its own balance-sheet depth.

Cash burn is almost entirely operational, not a side effect of building out assets, because free cash flow and operating cash flow were nearly the same in FY2025; this is an asset-light but not yet self-funding setup. With capex at just $2K, year-end liquidity depended partly on cash released from investing activities of $1.2M instead of fresh financing.

Financial Health Signals

Financial Profile 15/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of MedWellAI Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

MedWellAI Inc. has an operating margin of -477.6%, meaning the company retains $-478 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses.

Leverage

MedWellAI Inc. carries a low D/E ratio of -1.12, meaning only $-1.12 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 91/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

MedWellAI Inc.'s current ratio of 0.14 is below the typical benchmark, resulting in a score of 0/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

While MedWellAI Inc. generated -$849K in operating cash flow, capex of $2K consumed most of it, leaving -$851K in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.

Piotroski F-Score Weak

2/9

MedWellAI Inc. passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality Low Quality

0.24x

For every $1 of reported earnings, MedWellAI Inc. generates $0.24 in operating cash flow (-$849K OCF vs -$3.6M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk

-54.4x

MedWellAI Inc. earns $-54.4 in operating income for every $1 of interest expense (-$2.8M vs $52K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$595K

5Y CAGR+5.5%

MedWellAI Inc. generated $595K in revenue in fiscal year 2025.

EBITDA

-$2.8M

YoY+69.0%

MedWellAI Inc.'s EBITDA was -$2.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 69.0% from the prior year.

Net Income

-$3.6M

YoY+68.7%

MedWellAI Inc. reported -$3.6M in net income in fiscal year 2025. This represents an increase of 68.7% from the prior year.

EPS (Diluted)

$-0.49

YoY+82.0%

MedWellAI Inc. earned $-0.49 per diluted share (EPS) in fiscal year 2025. This represents an increase of 82.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow

-$851K

YoY+79.4%

MedWellAI Inc. generated -$851K in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 79.4% from the prior year.

Cash & Debt

$401K

YoY+594.1%

5Y CAGR+126.9%

10Y CAGR+24.2%

MedWellAI Inc. held $401K in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

YoY+21.2%

5Y CAGR-43.1%

MedWellAI Inc. had 6M shares outstanding in fiscal year 2025. This represents an increase of 21.2% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

-477.6%

5Y CAGR-254.2pp

MedWellAI Inc.'s operating margin was -477.6% in fiscal year 2025, reflecting core business profitability.

Net Margin

-606.5%

5Y CAGR-368.3pp

MedWellAI Inc.'s net profit margin was -606.5% in fiscal year 2025, showing the share of revenue converted to profit.

Return on Equity

N/A

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

$2K

5Y CAGR-55.1%

MedWellAI Inc. invested $2K in capex in fiscal year 2025, funding long-term assets and infrastructure.

MWAI Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$595K	$0-100.0%	$3.9M-41.0%	$6.6M+253.8%	$1.9M+307.6%	$454K
Cost of Revenue	N/A	$3.9M+45.6%	$2.7M-30.2%	$3.9M+320.3%	$920K-7.6%	$996K
Gross Profit	N/A	-$3.9M-438.0%	$1.2M-56.6%	$2.7M+188.0%	$931K+271.7%	-$542K
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$2.6M-72.5%	$9.3M-42.0%	$16.0M+397.4%	$3.2M-85.8%	$22.6M+6313.0%	$352K
Operating Income	-$2.8M+68.7%	-$9.1M+64.0%	-$25.2M-3558.7%	-$688K+96.8%	-$21.7M-2035.6%	-$1.0M
Interest Expense	$52K-37.1%	$83K-70.0%	$277K+1414.2%	$18K-95.8%	$436K-33.5%	$655K
Income Tax	$0	$0	$0	$0	$0	$0
Net Income	-$3.6M+68.7%	-$11.5M+54.7%	-$25.5M-4402.1%	-$566K+97.5%	-$22.4M-1973.7%	-$1.1M
EPS (Diluted)	$-0.49+82.0%	$-2.72+77.3%	$-11.98	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Revenue	$548K+470.6%	$96K-43.3%	$169K-39.8%	$281K+96.9%	$143K+12344.3%	$1K	N/A	$2.0M
Cost of Revenue	N/A	N/A	N/A	$0	$0	$0	N/A	$1.2M
Gross Profit	N/A	N/A	N/A	$281K+96.9%	$143K+12344.3%	$1K	N/A	$786K
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$410K+3.7%	$395K-14.9%	$465K-58.9%	$1.1M+80.6%	$625K+86.5%	$335K	N/A	$240K
Operating Income	-$274K+16.0%	-$326K+64.7%	-$923K+8.9%	-$1.0M-221.6%	-$315K+46.5%	-$589K	N/A	$320K
Interest Expense	$14K+5.4%	$13K-4.3%	$14K+6.8%	$13K-2.6%	$13K-0.5%	$13K	N/A	$23K
Income Tax	$0	$0	$0	$0	$0	$0	N/A	$0
Net Income	-$288K+55.9%	-$652K+42.2%	-$1.1M-91.7%	-$589K+12.7%	-$674K+44.6%	-$1.2M	N/A	$297K
EPS (Diluted)	$-0.05+44.4%	$-0.09	N/A	$-0.10+23.1%	$-0.130.0%	$-0.13	N/A	$0.01

MWAI Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$806K-79.6%	$3.9M-40.2%	$6.6M-59.5%	$16.3M+21.8%	$13.4M+2343.9%	$547K
Current Assets	$419K-83.9%	$2.6M+264.8%	$713K+44.6%	$493K-95.5%	$11.1M+111424.5%	$10K
Cash & Equivalents	$401K+594.1%	$58K-77.6%	$258K-47.4%	$490K-76.6%	$2.1M+31323.8%	$7K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	$0	N/A	N/A	N/A	N/A
Total Liabilities	$7.4M-4.8%	$7.8M+10.0%	$7.1M+24.8%	$5.7M+29.3%	$4.4M+570.2%	$656K
Current Liabilities	$3.1M-17.0%	$3.7M+23.8%	$3.0M+90.3%	$1.6M+470.5%	$274K-58.2%	$656K
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	$0
Total Equity	-$6.6M-71.4%	-$3.9M-658.1%	-$510K-104.8%	$10.6M+18.2%	$9.0M+8279.4%	-$110K
Retained Earnings	-$88.7M-4.2%	-$85.1M-16.4%	-$73.1M-58.3%	-$46.2M-2.5%	-$45.1M-104.3%	-$22.1M

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Total Assets	$461K-16.2%	$550K-31.7%	$806K-57.4%	$1.9M-32.8%	$2.8M-18.1%	$3.4M-12.8%	$3.9M-33.7%	$5.9M
Current Assets	$164K-32.0%	$242K-42.3%	$419K-45.3%	$766K-49.4%	$1.5M-14.1%	$1.8M-32.2%	$2.6M+28.9%	$2.0M
Cash & Equivalents	$138K-38.4%	$223K-44.4%	$401K-16.8%	$482K+105.6%	$235K-68.7%	$750K+1196.8%	$58K-84.9%	$382K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	$670K0.0%	$670K0.0%	$670K	$0	N/A
Total Liabilities	$7.9M+1.8%	$7.8M+4.7%	$7.4M-0.1%	$7.4M-10.1%	$8.3M0.0%	$8.3M+5.9%	$7.8M+5.1%	$7.4M
Current Liabilities	$7.7M+1.9%	$7.5M+146.6%	$3.1M+1.3%	$3.0M-20.7%	$3.8M+1.7%	$3.7M+1.5%	$3.7M+11.4%	$3.3M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$7.5M-3.1%	-$7.2M-9.1%	-$6.6M-19.5%	-$5.5M-1.6%	-$5.5M-12.9%	-$4.8M-25.0%	-$3.9M-160.6%	-$1.5M
Retained Earnings	-$89.6M-0.3%	-$89.3M-0.7%	-$88.7M-201.3%	$87.5M+200.7%	-$87.0M-0.8%	-$86.3M-1.4%	-$85.1M-2.9%	-$82.7M

MWAI Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	-$849K+79.4%	-$4.1M-20.4%	-$3.4M-6281.5%	$55K+103.5%	-$1.6M-133.6%	-$671K
Capital Expenditures	$2K	$0	$0-100.0%	$74K-97.8%	$3.3M+2568.3%	$123K
Free Cash Flow	-$851K+79.4%	-$4.1M-20.4%	-$3.4M-18818.1%	-$18K+99.6%	-$4.9M-511.6%	-$794K
Investing Cash Flow	$1.2M-71.4%	$4.2M+28.5%	$3.2M+243.1%	-$2.3M+75.1%	-$9.1M-4279.0%	$218K
Financing Cash Flow	$0+100.0%	-$243K-386.3%	-$50K-108.3%	$605K-95.3%	$12.8M+3006.6%	$411K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Operating Cash Flow	-$85K+50.2%	-$171K-57.0%	-$109K+60.9%	-$278K-28.4%	-$217K+11.5%	-$245K	N/A	-$914K
Capital Expenditures	N/A	N/A	$0	$0	$0-100.0%	$2K	N/A	$0
Free Cash Flow	N/A	N/A	-$109K+60.9%	-$278K-28.4%	-$217K+12.3%	-$247K	N/A	-$914K
Investing Cash Flow	-$750+89.7%	-$7K-126.2%	$28K-94.7%	$526K+276.1%	-$299K-131.9%	$937K	N/A	$1.4M
Financing Cash Flow	$0	$0	$0	$0	$0	$0	N/A	-$95K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

MWAI Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	30.1%-10.8pp	40.9%-9.4pp	50.3%+169.7pp	-119.4%
Operating Margin	-477.6%	N/A	-651.6%-641.1pp	-10.5%+1159.9pp	-1170.4%-947.0pp	-223.4%
Net Margin	-606.5%	N/A	-659.1%-650.5pp	-8.6%+1203.1pp	-1211.7%-973.5pp	-238.2%
Return on Equity	N/A	N/A	N/A	-5.3%+244.9pp	-250.2%	N/A
Return on Assets	-447.8%-155.5pp	-292.3%+94.0pp	-386.3%-382.8pp	-3.5%+164.4pp	-167.9%+30.0pp	-197.8%
Current Ratio	0.14-0.6	0.71+0.5	0.24-0.1	0.32-40.1	40.38+40.4	0.02
Debt-to-Equity	-1.12+0.9	-2.02+11.9	-13.93-14.5	0.54+0.0	0.49+0.5	0.00
FCF Margin	-143.0%	N/A	-88.7%-88.5pp	-0.3%+262.2pp	-262.4%-87.5pp	-174.9%

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Gross Margin	N/A	N/A	N/A	100.0%0.0pp	100.0%0.0pp	100.0%	N/A	39.6%
Operating Margin	-50.0%+289.3pp	-339.3%+205.5pp	-544.8%-184.6pp	-360.2%-139.7pp	-220.6%+51084.7pp	-51305.2%	N/A	16.2%
Net Margin	-52.4%+625.9pp	-678.4%-12.3pp	-666.0%-456.8pp	-209.2%+262.5pp	-471.7%+105455.7pp	-105927.4%	N/A	15.0%
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	-62.4%+56.2pp	-118.5%+21.6pp	-140.1%-109.0pp	-31.1%-7.2pp	-23.9%+11.4pp	-35.4%	N/A	5.0%
Current Ratio	0.02-0.0	0.03-0.1	0.14-0.1	0.25-0.1	0.40-0.1	0.47-0.2	0.71+0.1	0.61
Debt-to-Equity	-1.06+0.0	-1.08+0.0	-1.12+0.2	-1.34+0.2	-1.52+0.2	-1.71+0.3	-2.02+3.0	-5.01
FCF Margin	N/A	N/A	-64.2%+34.7pp	-98.9%+52.8pp	-151.7%+21375.1pp	-21526.7%	N/A	-46.1%

Note: Shareholder equity is negative (-$6.6M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.14), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

METAVESCO INC MVCO

$2.9M

Imining Technologies Inc IBKKF

$2.9M

Bluesky Digital Assets Corp BTCWF

$5.7M

Blockmint Techno BKLIF

$58K

Luxxfolio Hldgs LUXFF

$5.7M

Frequently Asked Questions

What is MedWellAI Inc.'s annual revenue?

MedWellAI Inc. (MWAI) reported $595K in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Is MedWellAI Inc. profitable?

No, MedWellAI Inc. (MWAI) reported a net income of -$3.6M in fiscal year 2025, with a net profit margin of -606.5%.

What is MedWellAI Inc.'s EBITDA?

MedWellAI Inc. (MWAI) had EBITDA of -$2.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is MedWellAI Inc.'s operating margin?

MedWellAI Inc. (MWAI) had an operating margin of -477.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is MedWellAI Inc.'s net profit margin?

MedWellAI Inc. (MWAI) had a net profit margin of -606.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is MedWellAI Inc.'s free cash flow?

MedWellAI Inc. (MWAI) generated -$851K in free cash flow during fiscal year 2025. This represents a 79.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is MedWellAI Inc.'s operating cash flow?

MedWellAI Inc. (MWAI) generated -$849K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are MedWellAI Inc.'s total assets?

MedWellAI Inc. (MWAI) had $806K in total assets as of fiscal year 2025, including both current and long-term assets.

What are MedWellAI Inc.'s capital expenditures?

MedWellAI Inc. (MWAI) invested $2K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How many shares does MedWellAI Inc. have outstanding?

MedWellAI Inc. (MWAI) had 6M shares outstanding as of fiscal year 2025.

What is MedWellAI Inc.'s current ratio?

MedWellAI Inc. (MWAI) had a current ratio of 0.14 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is MedWellAI Inc.'s debt-to-equity ratio?

MedWellAI Inc. (MWAI) had a debt-to-equity ratio of -1.12 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is MedWellAI Inc.'s return on assets (ROA)?

MedWellAI Inc. (MWAI) had a return on assets of -447.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is MedWellAI Inc.'s cash runway?

Based on fiscal year 2025 data, MedWellAI Inc. (MWAI) had $401K in cash against an annual operating cash burn of $849K. This gives an estimated cash runway of approximately 6 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Why is MedWellAI Inc.'s debt-to-equity ratio negative or unusual?

MedWellAI Inc. (MWAI) has negative shareholder equity of -$6.6M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is MedWellAI Inc.'s Piotroski F-Score?

MedWellAI Inc. (MWAI) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are MedWellAI Inc.'s earnings high quality?

MedWellAI Inc. (MWAI) has an earnings quality ratio of 0.24x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can MedWellAI Inc. cover its interest payments?

MedWellAI Inc. (MWAI) has an interest coverage ratio of -54.4x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is MedWellAI Inc.?

MedWellAI Inc. (MWAI) scores 15 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.